Application 208596
- Type
- ANDA
- Sponsor
- SIGMAPHARM LABS LLC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | TICAGRELOR | TICAGRELOR | TABLET;ORAL | 90MG | No | No |
| 002 | TICAGRELOR | TICAGRELOR | TABLET;ORAL | 60MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A208596-001 | TICAGRELOR | TICAGRELOR | 90MG | TABLET / ORAL | AB | 2020-04-07 | |
| A208596-002 | TICAGRELOR | TICAGRELOR | 60MG | TABLET / ORAL | AB | 2025-10-28 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A208596-001 | AB |
| A208596-002 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2022-09-29 23:25 UTC | 2022-09 | A208596-001 | TICAGRELOR | 90MG | TABLET / ORAL | 2020-04-07 | e64feba35796… | ||
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A208596-001 | TICAGRELOR | 90MG | TABLET / ORAL | 2020-04-07 | cb3db0bc1861… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A208596-001 | TICAGRELOR | 90MG | TABLET / ORAL | AB | 2020-04-07 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A208596-002 | TICAGRELOR | 60MG | TABLET / ORAL | AB | 2025-10-28 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A208596-001 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A208596-002 | AB | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A208596-001 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A208596-002 | AB | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A208596-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A208596-002 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A208596-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A208596-002 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A208596-001 | AB | 1 | 6a471c1ec25d… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A208596-001 | AB | 1 | 87673890dc5c… |
| 2021-03-12 10:30 UTC | 2021-03 | A208596-001 | AB | 1 | 5aa47cf7b7d7… |
| 2020-12-22 03:56 UTC | 2020-12 | A208596-001 | AB | 1 | 8869cabd3fbd… |
| 2020-11-12 02:37 UTC | 2020-11 | A208596-001 | AB | 1 | c0c555d07b60… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A208596-001 | AB | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A208596-002 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| TICAGRELOR | TICAGRELOR | Aphena Pharma Solutions - Tennessee, LLC | 5955a5f5-fbc7-8f67-e063-6394a90ada36 | 2026-08-18 | Boxed warning, Warnings, Adverse reactions | 208596 ANDA208596 |
| TICAGRELOR | TICAGRELOR | Novadoz Pharmaceuticals LLC | b1c29d47-960f-4fc4-b6ff-399e2c6eec4c | 2026-02-09 | Boxed warning, Warnings, Adverse reactions | 208596 ANDA208596 |
| TICAGRELOR | TICAGRELOR | AvPAK | 425024ab-e092-7a6d-e063-6294a90ae4f3 | 2025-10-29 | Boxed warning, Warnings, Adverse reactions | 208596 ANDA208596 |
| TICAGRELOR | TICAGRELOR | AvKARE | 40bb0fb0-2275-4df7-e063-6394a90ade2e | 2025-10-09 | Boxed warning, Warnings, Adverse reactions | 208596 ANDA208596 |
| TICAGRELOR | TICAGRELOR | AvKARE | 32ebf046-73e4-b11b-e063-6294a90a5bf4 | 2025-04-24 | Boxed warning, Warnings, Adverse reactions | 208596 ANDA208596 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.